Diseases & Conditions >
This topic is from 5-Minute Urology Consult
Dr. Gomella's off-label usage statement   About our sources

Bladder Cancer, Adenocarcinoma Updated 12/2009

Edmund Chiong, MBBS, H. Barton Grossman, MD
Feedback Form
Email       Print Section  |  Print Topic       Add to My Favorites

BASICS

  • Description
  • Epidemiology
  • Risk Factors
  • General Prevention
  • Pathophysiology
  • Associated Conditions

DIAGNOSIS

  • Signs and Symptoms
  • Tests
  • Differential Diagnosis

TREATMENT

  • Medication (Drugs)
  • Surgery
  • Additional Treatment | Radiotherapy

Ongoing Care

  • Prognosis
  • Complications
  • Follow-Up Recommendations
The following is an excerpt....
BASICS
Description
  • An uncommon and often aggressive nonurothelial malignancy of the bladder
  • It carries a poor prognosis, as it is frequently advanced at initial presentation (muscle invasive or metastatic).
Epidemiology
  • 0.5–2.0% of all primary bladder cancers.
  • Can arise from the urachus or the nonurachal epithelium; is also the most common tumor arising in exstrophy of the bladder.
  • A majority of nonurachal-, nonexstrophy-associated adenocarcinomas occur in men, frequently with an associated history of long-term inflammation or infection (it occurs more frequently in areas where schistosomia is endemic).
  • Urachal cancers: <1% of primary bladder cancers; ~1/3 of vesical adenocarcinomas.
  • Prevalence is unknown
Risk Factors
  • Chronic irritation, inflammation, or infection
  • Bladder exstrophy
  • Schistosomiasis
General Prevention

Avoidance of chronic bladder inflammation

Pathophysiology
  • Classification: 3 groups are related to ...

You must be logged in to fully access this content.

Sign In
Sign up for a 30-Day Free Trial

Sign up for a 30-Day FREE Trial now and receive access to all content.

Start free trial!

Have a book code?

Submit your book code to create your account.
See Also
Algorithms & Charts >